(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with Hypothermia, Accidental in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cano, C; Girón, R; Goya, P; Martín, MI; Paez, JA; Sánchez, E | 1 |
Bajaj, S; Barak, LS; Bowman, AL; Caron, MG; Deschamps, JR; Makriyannis, A; Paronis, C; Parrish, D; Peng, Y; Thakur, GA | 1 |
2 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and Hypothermia, Accidental
Article | Year |
---|---|
Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity.
Topics: Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Hypothermia; Injections, Intraperitoneal; Locomotion; Male; Mice; Mice, Inbred ICR; Molecular Structure; Morpholines; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Stereoisomerism; Thiadiazines; Vas Deferens | 2007 |
Novel adamantyl cannabinoids as CB1 receptor probes.
Topics: Adamantane; Analgesics; Animals; Arrestin; Body Temperature; Cannabinoid Receptor Agonists; Cannabinoids; Crystallography, X-Ray; Cyclic AMP; Dose-Response Relationship, Drug; Female; Hypothermia; Models, Molecular; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2013 |